NAD+, MOTS-c and SS-31: Three Different Mitochondrial Stories

The shared premise behind mitochondrial peptides

Mitochondrial peptides get discussed as a single category, which is where the confusion starts. Mitochondria generate most cellular ATP, and mitochondrial function declines measurably with age and under metabolic stress. That single observation is why three structurally unrelated compounds end up in the same conversation. Beyond the premise, they have very little in common. All three get grouped together as mitochondrial peptides, which is the first problem: only two of them are peptides at all.

NAD+ — the coenzyme, not a peptide

It is worth stating plainly: NAD+ is not a peptide. Nicotinamide adenine dinucleotide is a coenzyme that shuttles electrons between reactions, cycling between oxidised (NAD+) and reduced (NADH) forms. It sits at the centre of oxidative metabolism because nearly every dehydrogenase in the cell uses it.

The reason it appears in longevity and metabolic research is its second role. NAD+ is consumed as a substrate by sirtuins and PARP enzymes — involved in deacetylation signalling and DNA repair respectively. Because those enzymes use it up rather than merely catalysing with it, their activity is sensitive to how much is available. Tissue NAD+ concentrations decline with age across multiple models, and that observation is what the field is built around.

MOTS-c — a peptide written into mitochondrial DNA

MOTS-c is genuinely unusual. Mitochondrial DNA was long assumed to encode only the thirteen electron-transport-chain proteins plus structural RNAs. MOTS-c is a 16-amino-acid peptide encoded within the 12S ribosomal RNA region of that genome — a short open reading frame sitting inside a gene that was supposed to code for something else entirely.

The foundational work described it as promoting metabolic homeostasis and reducing obesity and insulin resistance in mouse models, with AMPK signalling as the central pathway.¹ Later work showed it translocates to the nucleus under metabolic stress and influences nuclear gene expression there² — a mitochondrial peptide acting as a retrograde signal to the nuclear genome, which is why it attracts attention well beyond metabolism.

SS-31 — targeting a membrane lipid

SS-31, also known as elamipretide, comes from the Szeto–Schiller series of mitochondria-targeting tetrapeptides. Its distinguishing feature is that it does not target an enzyme or a receptor. It targets a lipid.

Cardiolipin is a phospholipid found almost exclusively in the inner mitochondrial membrane, where it is essential for the structural organisation of the electron transport chain complexes and for cristae architecture. Cardiolipin is also readily damaged by oxidative stress, and that damage disrupts the assembly it supports. SS-31 associates with cardiolipin-containing membranes and modulates their surface electrostatics, which is the mechanism described in the biochemical literature.³

Of the three compounds here, SS-31 has progressed furthest toward the clinic, having been studied in trials for primary mitochondrial disease. That does not make it the most relevant to any given laboratory question — it makes it the one with the most human safety data behind it.

Why these mitochondrial peptides are not interchangeable

If you map the three onto where they act, the distinctions become obvious:

• NAD+ operates on substrate availability. It is about how much of a shared currency the cell has to spend across hundreds of reactions.
• MOTS-c operates on signalling. It is about a message sent from the mitochondrion to the rest of the cell, including to the nucleus.
• SS-31 operates on structure. It is about the physical organisation and integrity of the inner membrane on which the machinery sits.

Substrate, signal, structure. Three different layers of the same organelle. A research question about redox cofactor availability is not answered by a compound that binds cardiolipin, and vice versa.

Handling notes for mitochondrial peptides

MOTS-c and SS-31 are peptides and follow standard lyophilized-peptide practice — equilibrate the sealed vial, reconstitute gently in bacteriostatic water, aliquot, keep the dry stock frozen. The reconstitution guide covers the procedure in full.

NAD+ warrants a separate note. As a nucleotide rather than a peptide it is sensitive to hydrolysis and to alkaline conditions, and solutions are generally regarded as less forgiving than peptide solutions. Prepare what the experiment needs and keep exposure to room temperature short.

Mitochondrial peptides: frequently asked questions

SS-31 gets a fuller treatment of its own in SS-31 and cardiolipin, which covers why binding a structural lipid rather than a receptor changes how the compound has to be studied.

NAD+ can also be defended from the other direction — by blocking the enzyme that drains its precursor. See 5-Amino-1MQ, the NNMT inhibitor that is not a peptide.

References